This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
Questions about our CME?
Questions about our CME?

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Virtual Patient Simulations in Psoriasis - Integrating Systemic Biologics into Treatment Plans for Patients with Moderate to Severe Plaque Psoriasis

Virtual Patient Simulations in Psoriasis - Integrating Systemic Biologics into Treatment Plans for Patients with Moderate to Severe Plaque Psoriasis

Format

Patient Case Simulations

Time to Complete

30 minutes

Released

March 1, 2018

Expires

March 1, 2019
Add to Queue


Maximum Credits

0.50 / AMA PRA Category 1 CreditTM

Accredited Provider



This activity is provided by Paradigm Medical Communications, LLC.

Commercial Supporter

This activity is supported by educational grants from Lilly, Novartis Pharmaceuticals Corporation, and Valeant Pharmaceuticals North America, LLC.

Program Description

This is part 3 of a 3-part multimedia web initiative that explores the how, when and why for integrating systemic biologics into treatment plans for patients with moderate-to-severe plaque psoriasis. This activity provides a virtual patient simulation setting to review two cases and relevant therapeutic options with expert guidance.

Intended Audience

This activity has been designed to address the educational needs of dermatologists. It will also be of benefit to other clinicians engaged with or interested in the treatment of moderate-to-severe plaque psoriasis.

Educational Objectives

Upon proper completion of this activity, participants should be better able to:
  • Interpret efficacy and safety data from recent clinical trials regarding newer systemic biologic treatment options for psoriasis.
  • Recognize the role of patient-specific factors in formulating effective individualized care plans for patients with psoriasis.
  • Accreditor Disclosure of Conflicts of Interest Policy

    In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.

    Faculty

    Faculty
    Neil J. Korman, MD, PhD

    Professor of Dermatology
    University Hospital Cleveland Medical Center
    Case Western Reserve University
    Cleveland, OH

    Dr. Korman discloses the following:
    Advisory Board Member: AbbVie Inc; Celgene Corporation; Eli Lilly and Company; Janssen Pharmaceuticals Inc.;
    Regeneron Pharmaceuticals Inc; Sun Pharmaceutical Industries Ltd; Valeant Pharmaceuticals International Inc.
    Consultant: Novartis Pharmaceutical Corporation; Pfizer Inc
    Investigator: Eli Lilly and Company; Merck & Co, Inc., Pfizer Inc; Regeneron Pharmaceuticals Inc
    Speaker: AbbVie Inc.; Celgene Corporation; Eli Lilly and Company; Janssen Pharmaceuticals Inc.;
    Novartis Pharmaceutical Corporation

    Linda Stein Gold, MD
    Director of Clinical Research
    Department of Dermatology
    Henry Ford Hospital
    Detroit, MI

    Dr. Gold discloses the following:
    Advisor: AbbVie Inc.; Allergan, Inc.; Aqua Pharmaceuticals; Celgene Corporation; Galderma Laboratories;
    LEO Pharma Inc.; Novartis Pharmaceutical Corporation; Pfizer Inc; Taro Pharmaceutical Industries Ltd.; Valeant Pharmaceuticals International
    Investigator: Allergan, Inc.; Celgene Corporation; Galderma laboratories; Janssen Pharmaceuticals Inc.;
    LEO Pharma Inc.; Novartis Pharmaceutical Corporation; Pfizer Inc.; Valeant Pharmaceuticals International
    Speaker: Allergan, Inc.; Celgene Corporation; Galderma laboratories; LEO Pharma Inc.; Novartis Pharmaceutical Corporation; Pfizer Inc.; Taro Pharmaceutical Industries, Ltd; Valeant Pharmaceuticals International, Inc.

    Accreditor Disclosure

    Paradigm Medical Communications, LLC, staff members have no financial relationships to disclose.

    Independent peer reviewer has no financial relationships to disclose.

    Resolution of Conflict of Interest

    Paradigm Medical Communications, LLC, has implemented a system to resolve conflicts of interest for each CME activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.

    Credit

    0.50

    Type

    AMA PRA Category 1 Credit(s)TM

    Accreditation Statement

    Paradigm Medical Communications, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Designation Statement

    Paradigm Medical Communications, LLC, designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    PA Continuing Education

    PAs may claim a maximum of 0.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM   from organizations accredited by ACCME or a recognized state medical society.

    Nurse Practitioner Continuing Education

    The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

    Disclosure of Unlabeled Use

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.

    Disclaimer

    This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

    If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.

    As an ACCME-accredited provider, Paradigm Medical Communications, LLC, activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.

    Instructions

    To receive a CME certificate of participation, participants must:
    • Follow the "Start Activity" button to go to the Paradigm Medical Communications website, where you will complete the pre-test.
    • View the online activity in its entirety.
    • Complete and submit the online post-test and evaluation. You must answer 70% of the post-test questions correctly to earn credit. You will have unlimited opportunities to successfully complete the post-test.

    A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation. Your certificate will be saved on the Paradigm Medical Communications website and will not be available in your myCME CME History.

    For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.

    Technical Support: If you have any technical problems or playback issues email us at contactus@paradigmmc.com.

    There is no fee required for participation in this activity.

    Technical Requirements

    This certified CME activity is designed using HTML5 video and audio.

    For Desktops (Windows/Mac)
    Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher

    For Tablets (iPad/Android/Surface)
    iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher

    Terms of Use and Privacy Policy

    Disclaimer
    The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC, accepts no liability for the content referenced in this activity.

    Privacy Policy
    Paradigm Medical Communications, LLC, is committed to protecting the privacy of those who participate in the activities (herein referred to as “website") located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

    Security/safeguarding personal information
    This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

    Collection and use of your personal information
    The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC, to continuously improve the learning experience.

    Paradigm Medical Communications, LLC, does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC, will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC, staff members review individual test results to the extent necessary to record and track participants’ credits.

    myCME privacy policy

    Copyright

    © 2018 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.
    Add to Queue